Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects.
about
A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.A unifying mechanism for cancer cell death through ion channel activation by HAMLET.IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.Sensitization of (colon) cancer cells to death receptor related therapies: a report from the FP6-ONCODEATH research consortium.
P2860
Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Multifaceted targeting in canc ...... t the usual oncogene suspects.
@ast
Multifaceted targeting in canc ...... t the usual oncogene suspects.
@en
type
label
Multifaceted targeting in canc ...... t the usual oncogene suspects.
@ast
Multifaceted targeting in canc ...... t the usual oncogene suspects.
@en
prefLabel
Multifaceted targeting in canc ...... t the usual oncogene suspects.
@ast
Multifaceted targeting in canc ...... t the usual oncogene suspects.
@en
P2860
P1476
Multifaceted targeting in canc ...... t the usual oncogene suspects.
@en
P2093
Alexander Pintzas
Konstantinos Drosopoulos
P2860
P304
P356
10.1517/14728222.11.5.641
P407
P577
2007-05-01T00:00:00Z